Characterization of the effects of pancreatic polypeptide in the regulation of energy balance

Gastroenterology

Volumn 124, Issue 5, 2003, Pages 1325-1336

  Asakawa, Akihiro ^a   Inui, Akio ^a   Yuzuriha, Hideki ^a   Ueno, Naohiko ^a   Katsuura, Goro ^b   Fujimiya, Mineko ^c   Fujino, Masayuki A ^d   Niijima, Akira ^g   Meguid, Michael M ^e,f   Kasuga, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f State University of New York Upstate Medical University: College of Medicine   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CYTOKINE; GHRELIN; LEPTIN; NEUROPEPTIDE; NEUROPEPTIDE Y; OREXIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; UROCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; FATTY LIVER; FOOD INTAKE; GENE EXPRESSION; GLUCOSE METABOLISM; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PANCREAS; PRIORITY JOURNAL; STOMACH EMPTYING; VAGUS NERVE; VAGUS NERVE STIMULATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

EID: 0037847510     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00216-6     Document Type: Article

References (40)

1. Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-1538.
2. Braddon FE, Rodgers B, Wadsworth ME, Davies JM. Onset of obesity in a 36 year birth cohort study. BMJ 1986;293:299-303.
3. Taylor IL. Pancreatic polypeptide family: pancreatic polypeptide, neuropeptide Y and peptide YY. In: Rauner BB, Makhlouf GM, Schultz SG, eds. Handbook of physiology, section 6. Volume 2. Bethesda: American Physiological Society, 1989:475-543.
4. Ueno N, Inui A, Iwamoto M, Kaga T, Asakawa A, Okita M, Fujimiya M, Nakajima Y, Ohmoto Y, Ohnaka M, Nakaya Y, Miyazaki JI, Kasuga M. Decreased food intake and body weight in pancreatic polypeptide overexpressing mice. Gastroenterology 1999;117:1427-1432.
5. Holm VA. The diagnosis of Prader-Willi Syndrome, In: Holm VA, Sulzbacher SJ, Pipes PL, eds. Prader-Willi syndrome. Baltimore: University Park Press, 1979:27-45.
6. Marco J, Zulueta MA, Correas I, Villanueva ML. Reduced pancreatic polypeptide secretion in obese subjects. J Clin Endocrinol Metab 1980;50:744-747.
7. Lassmann V, Vague P, Vialettes B, Simon MC. Low plasma levels of pancreatic polypeptide in obesity. Diabetes 1980;29:428-430.
8. Uhe AM, Szmukler GI, Collier GR, Hansky J, O'Dea K, Young GP. Potential regulators of feeding behavior in anorexia nervosa. Am J Clin Nutr 1992;55:28-32.
9. Bray GA, York DA. The MONA LISA hypothesis in the time of leptin. Recent Prog Horm Res 1998;53:95-118.
10. Inui A. Transgenic approach to the study of body weight regulation. Pharmacol Rev 2000;52:35-61.
11. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68-100.
12. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG, Central nervous system control of food intake. Nature 2000;404:661-671.
13. Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2001;2:551-560.
14. Nakajima M, Inui A, Teranishi A, Miura M, Hirosue Y, Okita M, Himori N, Baba S, Kasuga M. Effects of PP family peptides of feeding and learning behavior in mice. J Pharmacol Exp Ther 1994;268:1010-1014.
15. Asakawa A, Inui A, Ueno N, Fujimiya M, Fujino MA, Kasuga M. Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptides 1999;20:1445-1448.
16. Katsuura G, Asakawa A, Inui A. Roles of pancreatic polypeptide in regulation of food intake. Peptides 2002;23:323-329.
17. Inui A, Okita M, Miura M, Hirosue Y, Mizuno N, Baba S, Kasuga M. Plasma and cerebroventricular fluid levels of pancreatic polypeptide in the dog: effects of feeding, insulin-induced hypo-glycemia, and physical exercise. Endocrinology 1993;132:1235-1239.
18. Duggan JP, Booth DA. Obesity, overeating, and rapid gastric emptying in rats with ventromedial hypothalamic lesions. Science 1986;231:609-611.
19. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 1999;59:4493-4501.
20. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002;52:72-91.
21. Whitcomb DC, Taylor SR, Vigna SR. Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. Am J Physiol 1990;259:G687-G691.
22. Rogers RC, McTigue DM, Hermann GE. Vagal control of digestion: modulation by central neural and peripheral endocrine factors. Neurosci Biobehav Rev 1996;20:57-66.
23. Mctigue DM, Edwards NK, Rogers RC. Pancreatic polypeptide in dorsal vagal complex stimulates gastric acid secretion and motility in rats. Am J Physiol 1993;265:G1169-G1176.
24. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001;120:337-345.
25. Geary N, Sauter JL, Noh U. Glucagon acts in the liver to control spontaneous meal size in rats. Am J Physiol 1993;264:R116-R122.
26. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-198.
27. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002;8:643-644.
28. Berntson GG, Zipf WB, O'Dorisio TM, Hoffman JA, Chance RE. Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 1993;14:497-503.
29. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
30. Flier JS, Flier EM. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998;92:437-440.
31. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
32. Schwartz MW, Brunzell JD. Regulation of body adiposity and the problem of obesity. Arterioscler Thromb Vasc Biol 1997;17:233-238.
33. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999;103:253-259.
34. Soga M, Kishimoto Y, Kawaguchi J, Nakai Y, Kawamura Y, Inagaki S, Katoh K, Oohara T, Makino S, Oshima I. The FLS mouse: a new inbred strain with spontaneous fatty liver. Lab Anim Sci 1999;49:269-275.
35. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002;34:255-262.
36. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-1850.
37. Inui A. Eating behavior in anorexia nervosa - an excess of both orexigenic and anorexigenic signalling? Mol Psychiatr 2001;6:620-624.
38. Vaswani K, Tejwani GA, Mousa S. Stress induced differential intake of various diets and water by rat: the role of the opiate system. Life Sci 1983;32:1983-1996.
39. Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000;24:S50-55.
40. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR. Gut hormone PYY3-36 physiologically inhibits food intake. Nature 2002;418:650-654.